EGFR and metastatic colorectal cancer: Panitumumab is a human anti-epidermal growth factor receptor (EGFR) monoclonal antibody indicated in the treatment of patients with wild type Ras (WT) metastatic colorectal cancer (mCRC), Panitumumab works by binding to the extracellular domain of the EGFR preventing its activation.